Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disease presenting with combinations of autonomic dysfunction, parkinsonism, cerebellar ataxia and/or pyramidal signs. Oligodendroglial cytoplasmic inclusions (GCIs) rich in α-synuclein (α-syn) constitute the disease hallmark, accompanied by neuronal loss and activation of glial cells which indicate neuroinflammation. Recent studies demonstrate that α-syn may be released from degenerating neurons to mediate formation of abnormal inclusion bodies and to induce neuroinflammation which, interestingly, might also favor the formation of intracellular α-syn aggregates as a consequence of cytokine release and the shift to a pro-inflammatory environment. Here, we critically review the relationships between α-syn and astrocytic and microglial activation in MSA to explore the potential of therapeutics which target neuroinflammation.

Highlights

  • MULTIPLE SYSTEM ATROPHY AND α-SYNUCLEINMultiple System Atrophy (MSA) is a complex progressive neurodegenerative disease which affects 3.4–4.9 cases/100,000 with 0.6–0.7/100,000 new cases each year

  • We critically review the relationships between α-syn and astrocytic and microglial activation in Multiple system atrophy (MSA) to explore the potential of therapeutics which target neuroinflammation

  • In the context of neurodegenerative diseases, persistent intra- and extracellular imbalances are known to trigger and chronically perpetuate this response, which is dominated by microglia and astrocytes (Takeuchi, 2013)

Read more

Summary

Introduction

MULTIPLE SYSTEM ATROPHY AND α-SYNUCLEINMultiple System Atrophy (MSA) is a complex progressive neurodegenerative disease which affects 3.4–4.9 cases/100,000 with 0.6–0.7/100,000 new cases each year. Oligodendroglial cytoplasmic inclusions (GCIs) rich in α-synuclein (α-syn) constitute the disease hallmark, accompanied by neuronal loss and activation of glial cells which indicate neuroinflammation.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call